Markets

Stock Market Today: Big Deal! Big Deal! Stocks Solidly in the Black on 'M&A Monday'

Big dealmaking from Nvidia (NVDA) and Gilead Sciences (GILD), as well as renewed COVID vaccine hopes, sent a jolt into stocks Monday.

A roaring day of M&A and other tie-ups helped inject some life into the stock market Monday, as did renewed hopes for a successful vaccine before the end of 2020.

Chipmaker Nvidia (NVDA, 5.8%) announced late Sunday that it would buy mobile chip maker Arm Holdings from Japanese conglomerate SoftBank (SFTBY, +7.9%) for $40 billion in cash and stock.

"We like the deal for NVDA given Arm's licensing model, which provides high visibility, as well as ecosystem across the mobile space," writes CFRA analyst Angelo Zino, who maintained his Buy rating on Nvidia shares. "NVDA expects the deal to be immediately accretive to EPS and support margin expansion."

While Microsoft (MSFT, +0.7%) revealed Sunday that its bid for the U.S. operations of controversial Chinese social media platform TikTok was rejected by parent firm ByteDance, but Oracle (ORCL, +4.3%) confirmed Monday that it would become a "trusted technology partner" for the app. The deal, which is not an outright sale, still must pass muster with the White House.

And biotech Gilead Sciences (GILD, +2.2%) announced Sunday that it would bolster its cancer-treatment portfolio with a $21 billion buyout of Immunomedics (IMMU, +98.0%).

"Following a disappointing August with the CRL for filgotinib, we are highly encouraged with the continued expansion into oncology," write Credit Suisse analysts, who rate the stock at Neutral (equivalent of Hold). "We see this as closer to a ‘transformative’ deal, given the size and current peak potential for Trodelvy (~$3.5B in peak sales per Visible Alpha consensus)."

Also over the weekend, Pfizer CEO Albert Bouris said he thinks key late-stage trial data for its COVID-19 vaccine should be available by late October, which, if positive, could mean possible U.S. distribution before the end of the year.

The major indices all were sent solidly higher, with the Dow Jones Industrial Average closing up 1.2% to 27,993.

Other action in the stock market today:

  • The Nasdaq Composite finished with a 1.9% gain to 11,056.
  • The S&P 500 improved by 1.3% to 3,383.
  • The small-cap Russell 2000 rocketed ahead 2.7% to 1,536.

Can Stocks Climb the "Stairs"?

The market's volatility favored investors Monday, and it could be part of a pattern of lurching market moves that ultimately sees stocks set new highs.

"The 7% correction in the S&P 500 over the past six trading sessions is likely the first of a few 3%-7% drawdowns followed by new highs as the market stairsteps higher like the fall of 2009, driven by election-year angst and the extended nature of the market-cap-weighted indices," Canaccord Genuity equity strategist Tony Dwyer says. He also reminds investors that the markets have an ally in the Federal Reserve.

"Unlike the political backdrop, which is totally unpredictable, we know the Fed intends to keep rates at zero and to keep intervening when there are any signs of stress," Dwyer says. "The uncertainty around the Fed is not whether it will continue to support the economy and risk assets, but what tools it may use to be even more accommodative."

For those eager to take a more active approach to their portfolio, these drawbacks could be the perfect opportunity to snare some of the new bull market's highest-potential plays, or a chance to buy already-value-priced equities for an even bigger discount.

For others, it could be heartburn waiting to happen. The easiest way to keep from sweating Wall Street's ebbs and flows is to put someone else at the helm -- and when you do so via target-date funds, you get the whole enchilada: equities, fixed income, and in some cases, even real estate and commodities. But which target-date funds are for you? We've explored 10 of the biggest and best target-date fund families and highlighted some of their most important characteristics to help you decide.

Kyle Woodley was long MSFT as of this writing.

Most Popular

How a Third Stimulus Check Could Differ From the First and Second Payments
Coronavirus and Your Money

How a Third Stimulus Check Could Differ From the First and Second Payments

There's a big push in Washington for a third round of stimulus payments. But the amount and eligibility rules for your third stimulus check could be d…
January 27, 2021
Where's My Stimulus Check? Use the IRS's "Get My Payment" Portal to Get an Answer
Coronavirus and Your Money

Where's My Stimulus Check? Use the IRS's "Get My Payment" Portal to Get an Answer

The IRS has an online tool that lets you track the status of your second stimulus check.
January 18, 2021
Biden's Stimulus Plan Includes $3,000 Child Tax Credits
Coronavirus and Your Money

Biden's Stimulus Plan Includes $3,000 Child Tax Credits

The president is calling for a temporary tax credit of $3,000 per child (more for younger children).
January 27, 2021

Recommended

How WSB Beat Hedge Funds at Their Own Game
stocks

How WSB Beat Hedge Funds at Their Own Game

Short squeezes and stock mania are nothing new. But the Reddit community WallStreetBets (WSB) has put its own spin on an old formula via GME and other…
January 28, 2021
Stock Market Today 1/27/21: Markets Tumble, But 'Reddit Stocks' Story Isn't Over
Stock Market Today

Stock Market Today 1/27/21: Markets Tumble, But 'Reddit Stocks' Story Isn't Over

The major indices delivered significant losses Wednesday; spared were stocks such as GameStop and AMC, which soared amid a push from a corner of the i…
January 27, 2021
When to Give Up on a Stock
Becoming an Investor

When to Give Up on a Stock

Selling should have little to do with price. What matters is the business itself and whether it has changed for the worse.
January 27, 2021
6 Contrarian Stock Picks With Tons of Upside
stocks

6 Contrarian Stock Picks With Tons of Upside

These companies are out of favor for one reason or another, but they could pay off for patient investors.
January 27, 2021